Bio-Rad Laboratories [BIO] vs Stryker [SYK] Detailed Stock Comparison

Bio-Rad Laboratories Inc.

NYSE
Loading...

Stryker Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Bio-Rad Laboratories Inc. wins in 11 metrics, Stryker Corporation wins in 9 metrics, with 0 ties. Bio-Rad Laboratories Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bio-Rad Laboratories Inc. Stryker Corporation Better
P/E Ratio (TTM) 10.98 39.21 Bio-Rad Laboratories Inc.
Price-to-Book Ratio 1.11 5.62 Bio-Rad Laboratories Inc.
Debt-to-Equity Ratio 18.58 72.97 Bio-Rad Laboratories Inc.
PEG Ratio -0.05 0.72 Stryker Corporation
EV/EBITDA 18.75 19.90 Bio-Rad Laboratories Inc.
Profit Margin (TTM) 29.42% 12.92% Bio-Rad Laboratories Inc.
Operating Margin (TTM) 8.87% 27.24% Stryker Corporation
EBITDA Margin (TTM) 8.87% 27.24% Stryker Corporation
Return on Equity 10.84% 15.08% Stryker Corporation
Return on Assets (TTM) 1.67% 7.92% Stryker Corporation
Free Cash Flow (TTM) $374.60M $4.28B Stryker Corporation
Dividend Yield N/A 0.97% N/A
1-Year Return 26.01% -17.25% Bio-Rad Laboratories Inc.
Price-to-Sales Ratio (TTM) 3.20 5.02 Bio-Rad Laboratories Inc.
Enterprise Value $8.09B $138.30B Stryker Corporation
EV/Revenue Ratio 3.13 5.51 Bio-Rad Laboratories Inc.
Gross Profit Margin (TTM) 49.80% 64.54% Stryker Corporation
Revenue per Share (TTM) $95 $66 Bio-Rad Laboratories Inc.
Earnings per Share (Diluted) $27.85 $8.40 Bio-Rad Laboratories Inc.
Beta (Stock Volatility) 1.16 0.93 Stryker Corporation
Short % of Float 0.00% 1.20% Bio-Rad Laboratories Inc.

Bio-Rad Laboratories Inc. vs Stryker Corporation Stock Performance Analysis

Loading Price Chart...

BIO
SYK

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bio-Rad Laboratories Inc.1.17%-0.70%16.87%10.73%-6.05%-5.24%
Stryker Corporation-1.36%2.13%0.38%-11.91%-13.33%-11.56%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bio-Rad Laboratories Inc.26.01%-24.07%-54.09%102.91%143.91%328.31%
Stryker Corporation-17.25%6.06%22.47%172.95%440.98%592.85%

Performance & Financial Health Analysis: Bio-Rad Laboratories Inc. vs Stryker Corporation

MetricBIOSYK
Market Information
Market Cap i$7.60B$126.25B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i239,6251,881,406
90 Day Avg. Volume i284,7852,161,139
Last Close$289.28$307.94
52 Week Range$222.80 - $343.12$281.00 - $404.87
% from 52W High-15.69%-23.94%
All-Time High$832.70 (Aug 30, 2021)$406.19 (Jan 27, 2025)
% from All-Time High-65.26%-24.19%
Growth Metrics
Quarterly Revenue Growth0.04%0.11%
Quarterly Earnings Growth0.04%0.56%
Financial Health
Profit Margin (TTM) i0.29%0.13%
Operating Margin (TTM) i0.09%0.27%
Return on Equity (TTM) i0.11%0.15%
Debt to Equity (MRQ) i18.5872.97
Cash & Liquidity
Book Value per Share (MRQ)$276.16$58.61
Cash per Share (MRQ)$57.08$10.71
Operating Cash Flow (TTM) i$532.20M$5.04B
Levered Free Cash Flow (TTM) i$256.55M$4.17B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A$3.40

Valuation & Enterprise Metrics Analysis: Bio-Rad Laboratories Inc. vs Stryker Corporation

MetricBIO (Apr 24, 2026)SYK (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i10.9839.21
Forward P/E i26.9419.67
PEG Ratio i-0.050.72
Price to Sales (TTM) i3.205.02
Price to Book (MRQ) i1.115.62
Market Capitalization
Market Capitalization i$7.60B$126.25B
Enterprise Value i$8.09B$138.30B
Enterprise Value Metrics
Enterprise to Revenue i3.135.51
Enterprise to EBITDA i18.7519.90
Risk & Other Metrics
Beta i1.160.93
Book Value per Share (MRQ) i$276.16$58.61

Financial Statements Comparison: Bio-Rad Laboratories Inc. vs Stryker Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBIO (2025)SYK (2025)
Revenue/Sales i2.58B25.12B
Cost of Goods Sold i1.24B9.05B
COGS % of Revenue i48.1%36.0%
Gross Profit i1.34B16.07B
Gross Margin i51.9%64.0%
Research & Development i275.60M1.62B
Operating Income (EBIT) i218.60M5.06B
Operating Margin i8.5%20.1%
EBITDA i480.70M6.48B
EBITDA Margin i18.6%25.8%
Pre-Tax Income i995.50M4.51B
Pre-Tax Income % of Revenue i38.5%18.0%
Income Tax i235.60M1.27B
Income Tax % of Revenue i9.1%5.0%
Net Income (Profit) i759.90M3.25B
Profit Margin i29.4%12.9%

Balance Sheet & Liquidity Metrics

MetricBIO (2025)SYK (2025)
Cash & Equivalents i529.80M4.01B
Total Current Assets i2.91B14.76B
Total Current Assets % of Revenue i112.5%58.7%
Total Current Liabilities i517.00M7.79B
Total Current Liabilities % of Revenue i20.0%31.0%
Long-Term Debt i1.35B14.86B
Long-Term Debt % of Revenue i52.2%59.2%
Total Shareholders Equity i7.45B22.42B
Retained Earnings i8.18B20.47B
Retained Earnings % of Revenue i316.5%81.5%
Property, Plant & Equipment i1.49B1.79B

Cash Flow Statement Comparison

MetricBIO (2025)SYK (2025)
Operating Cash Flow i1.25B4.70B
Operating Cash Flow % of Revenue i48.4%18.7%
Capital Expenditures i-157.50M-761.00M
Free Cash Flow i374.60M4.28B
FCF Margin i14.5%17.1%
Debt Repayment i-500,000-1.40B
Common Stock Repurchase i-295.50MN/A

Short Interest & Institutional Ownership Analysis

MetricBIOSYK
Shares Short i264.42M
Short Ratio i0.001.95
Short % of Float i0.00%1.20%
Shares Outstanding i26.99M382.50M
Float Shares i21.13M346.55M
% Held by Insiders i16.20%5.37%
% Held by Institutions i91.50%82.09%
% Held by Public i-7.70%12.54%

Dividend Analysis & Yield Comparison: Bio-Rad Laboratories Inc. vs Stryker Corporation

MetricBIOSYK
Last 12-Month Dividend iN/A$3.40
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A$3.23
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends iN/A$9.69
Ex-Dividend DateN/ADec 31, 2025